{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+of+Adalimumab", "query": { "intervention": "Placebo of Adalimumab" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 85, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+of+Adalimumab&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T17:53:33.112Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00595413", "title": "Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Placebo matched to atacicept", "type": "DRUG" }, { "name": "Atacicept: with loading dose", "type": "DRUG" }, { "name": "Atacicept", "type": "DRUG" }, { "name": "Adalimumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 311, "start_date": "2007-09", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2016-02-17", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 1, "location_summary": "Rockland, Massachusetts", "locations": [ { "city": "Rockland", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00595413" }, { "nct_id": "NCT04655807", "title": "A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "JNJ-64304500", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Ustekinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2021-03-03", "completion_date": "2023-09-04", "has_results": false, "last_update_posted_date": "2025-04-27", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04655807" }, { "nct_id": "NCT02187055", "title": "An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rhematoid Arthritis" ], "interventions": [ { "name": "Tofacitinib with methotrexate", "type": "DRUG" }, { "name": "Tofacitinib without methotrexate", "type": "DRUG" }, { "name": "Adalimumab with methotrexate", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1152, "start_date": "2014-08", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-06-27", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 60, "location_summary": "Huntsville, Alabama • Gilbert, Arizona • Covina, California + 47 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02187055" }, { "nct_id": "NCT03259074", "title": "Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "GP2017 (adalimumab biosimilar)", "type": "BIOLOGICAL" }, { "name": "AIN457 150 mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 859, "start_date": "2017-11-30", "completion_date": "2021-11-29", "has_results": true, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 19, "location_summary": "Mesa, Arizona • Escondido, California • La Mesa, California + 16 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Escondido", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03259074" }, { "nct_id": "NCT06972446", "title": "A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Lutikizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Ravagalimab", "type": "DRUG" }, { "name": "ABBV-8736", "type": "DRUG" }, { "name": "ABBV-701", "type": "DRUG" }, { "name": "ABBV-848", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2025-06-20", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 49, "location_summary": "Peoria, Arizona • Jonesboro, Arkansas • Beverly Hills, California + 42 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06972446" }, { "nct_id": "NCT03153319", "title": "Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Mucopolysaccharidosis I", "Mucopolysaccharidosis II", "Mucopolysaccharidosis VI" ], "interventions": [ { "name": "Adalimumab Injection [Humira]", "type": "DRUG" }, { "name": "Saline Solution for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 14, "start_date": "2017-06-05", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03153319" }, { "nct_id": "NCT01264770", "title": "Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Fostamatinib and placebo injections", "type": "DRUG" }, { "name": "Adalimumab and placebo of fostamatinib", "type": "DRUG" }, { "name": "Placebo of fostamatinib, fostamatinib, and placebo injections", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 644, "start_date": "2011-01", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2014-05-06", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01264770" }, { "nct_id": "NCT02207244", "title": "A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Guselkumab 100 mg", "type": "DRUG" }, { "name": "Placebo for guselkumab", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo for adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 992, "start_date": "2014-11-03", "completion_date": "2020-07-01", "has_results": true, "last_update_posted_date": "2021-07-22", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Bakersfield, California • Los Angeles, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02207244" }, { "nct_id": "NCT03816397", "title": "Adalimumab in JIA-associated Uveitis Stopping Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Uveitis", "JIA" ], "interventions": [ { "name": "Adalimumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Nisha Acharya", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 87, "start_date": "2020-03-15", "completion_date": "2025-04-03", "has_results": true, "last_update_posted_date": "2025-05-11", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 11, "location_summary": "Sacramento, California • San Francisco, California • Aurora, Colorado + 8 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03816397" }, { "nct_id": "NCT01674413", "title": "Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Adalimumab", "type": "DRUG" }, { "name": "Adalimumab PRN", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peter Higgins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2013-10", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2017-05-24", "last_synced_at": "2026-09-24T17:53:33.112Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01674413" } ] }